Annual EBITDA:
$928.62M-$46.64M(-4.78%)Summary
- As of today, CRL annual EBITDA is $928.62 million, with the most recent change of -$46.64 million (-4.78%) on December 31, 2024.
- During the last 3 years, CRL annual EBITDA has risen by +$60.65 million (+6.99%).
- CRL annual EBITDA is now -4.78% below its all-time high of $975.26 million, reached on December 31, 2023.
Performance
CRL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$236.25M-$15.60M(-6.19%)Summary
- As of today, CRL quarterly EBITDA is $236.25 million, with the most recent change of -$15.60 million (-6.19%) on September 27, 2025.
- Over the past year, CRL quarterly EBITDA has dropped by -$303.00 thousand (-0.13%).
- CRL quarterly EBITDA is now -10.92% below its all-time high of $265.20 million, reached on June 25, 2022.
Performance
CRL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$907.49M-$303.00K(-0.03%)Summary
- As of today, CRL TTM EBITDA is $907.49 million, with the most recent change of -$303.00 thousand (-0.03%) on September 27, 2025.
- Over the past year, CRL TTM EBITDA has dropped by -$43.91 million (-4.62%).
- CRL TTM EBITDA is now -7.69% below its all-time high of $983.08 million, reached on June 25, 2022.
Performance
CRL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -4.8% | -0.1% | -4.6% |
| 3Y3 Years | +7.0% | +4.2% | -7.0% |
| 5Y5 Years | +57.2% | +21.4% | +35.9% |
CRL EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -4.8% | +7.0% | -7.6% | +17.8% | -7.1% | at low |
| 5Y | 5-Year | -4.8% | +57.2% | -10.9% | +21.5% | -7.7% | +35.9% |
| All-Time | All-Time | -4.8% | +2365.1% | -10.9% | +1193.8% | -7.7% | +4223.2% |
CRL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $236.25M(-6.2%) | $907.49M(-0.0%) |
| Jun 2025 | - | $251.84M(+15.1%) | $907.79M(-0.4%) |
| Mar 2025 | - | $218.88M(+9.2%) | $911.64M(-1.0%) |
| Dec 2024 | $928.62M(-4.8%) | $200.52M(-15.2%) | $921.09M(-3.2%) |
| Sep 2024 | - | $236.55M(-7.5%) | $951.39M(-1.0%) |
| Jun 2024 | - | $255.69M(+12.0%) | $961.42M(+1.2%) |
| Mar 2024 | - | $228.33M(-1.1%) | $949.57M(-1.8%) |
| Dec 2023 | $975.26M(+2.0%) | - | - |
| Dec 2023 | - | $230.82M(-6.4%) | $967.26M(-0.9%) |
| Sep 2023 | - | $246.57M(+1.1%) | $975.66M(+2.1%) |
| Jun 2023 | - | $243.84M(-0.9%) | $955.77M(-2.2%) |
| Mar 2023 | - | $246.03M(+2.8%) | $977.13M(+1.3%) |
| Dec 2022 | $956.46M(+10.2%) | $239.23M(+5.5%) | $964.29M(-1.2%) |
| Sep 2022 | - | $226.68M(-14.5%) | $976.34M(-0.7%) |
| Jun 2022 | - | $265.20M(+13.7%) | $983.08M(+4.5%) |
| Mar 2022 | - | $233.19M(-7.2%) | $940.45M(+4.2%) |
| Dec 2021 | $867.97M(+25.1%) | $251.28M(+7.6%) | $902.42M(+6.7%) |
| Sep 2021 | - | $233.42M(+4.9%) | $845.58M(+4.8%) |
| Jun 2021 | - | $222.56M(+14.0%) | $806.78M(+10.8%) |
| Mar 2021 | - | $195.16M(+0.4%) | $727.84M(+5.2%) |
| Dec 2020 | $693.88M(+17.5%) | $194.44M(-0.1%) | $691.88M(+3.6%) |
| Sep 2020 | - | $194.61M(+35.5%) | $668.01M(+6.9%) |
| Jun 2020 | - | $143.63M(-9.8%) | $624.61M(+0.1%) |
| Mar 2020 | - | $159.20M(-6.7%) | $623.69M(+6.3%) |
| Dec 2019 | $590.68M(+13.6%) | $170.57M(+12.8%) | $586.59M(+4.4%) |
| Sep 2019 | - | $151.21M(+6.0%) | $562.08M(+3.2%) |
| Jun 2019 | - | $142.70M(+16.9%) | $544.70M(+1.6%) |
| Mar 2019 | - | $122.10M(-16.4%) | $536.05M(+3.1%) |
| Dec 2018 | $519.91M(+21.4%) | $146.07M(+9.1%) | $519.86M(+10.6%) |
| Sep 2018 | - | $133.83M(-0.2%) | $470.21M(+5.4%) |
| Jun 2018 | - | $134.05M(+26.6%) | $446.20M(+4.7%) |
| Mar 2018 | - | $105.92M(+9.9%) | $426.10M(+0.2%) |
| Dec 2017 | $428.32M(+9.1%) | $96.42M(-12.2%) | $425.30M(-1.9%) |
| Sep 2017 | - | $109.82M(-3.6%) | $433.52M(+3.4%) |
| Jun 2017 | - | $113.96M(+8.4%) | $419.12M(+3.6%) |
| Mar 2017 | - | $105.11M(+0.5%) | $404.58M(+6.6%) |
| Dec 2016 | $392.75M(+25.5%) | $104.63M(+9.7%) | $379.35M(+7.6%) |
| Sep 2016 | - | $95.42M(-4.0%) | $352.54M(+3.6%) |
| Jun 2016 | - | $99.41M(+24.4%) | $340.37M(+6.1%) |
| Mar 2016 | - | $79.89M(+2.7%) | $320.95M(+4.7%) |
| Dec 2015 | $312.97M(+6.1%) | $77.82M(-6.5%) | $306.49M(+0.3%) |
| Sep 2015 | - | $83.25M(+4.1%) | $305.51M(+3.4%) |
| Jun 2015 | - | $79.99M(+22.3%) | $295.58M(+0.4%) |
| Mar 2015 | - | $65.42M(-14.9%) | $294.28M(+1.3%) |
| Dec 2014 | $294.94M(+15.5%) | $76.84M(+4.8%) | $290.51M(+4.6%) |
| Sep 2014 | - | $73.33M(-6.8%) | $277.69M(+1.9%) |
| Jun 2014 | - | $78.68M(+27.6%) | $272.60M(+5.7%) |
| Mar 2014 | - | $61.66M(-3.7%) | $257.80M(-0.5%) |
| Dec 2013 | $255.46M(+0.9%) | $64.03M(-6.2%) | $259.21M(+1.6%) |
| Sep 2013 | - | $68.23M(+6.8%) | $255.16M(+2.2%) |
| Jun 2013 | - | $63.88M(+1.3%) | $249.67M(-2.1%) |
| Mar 2013 | - | $63.07M(+5.2%) | $255.13M(-0.6%) |
| Dec 2012 | $253.16M | $59.97M(-4.4%) | $256.71M(-5.3%) |
| Sep 2012 | - | $62.75M(-9.5%) | $271.01M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $69.34M(+7.2%) | $266.88M(-2.6%) |
| Mar 2012 | - | $64.65M(-12.9%) | $274.04M(+0.2%) |
| Dec 2011 | $284.14M(+19.7%) | $74.27M(+26.7%) | $273.46M(+2.5%) |
| Sep 2011 | - | $58.62M(-23.4%) | $266.82M(-0.5%) |
| Jun 2011 | - | $76.50M(+19.4%) | $268.22M(+9.2%) |
| Mar 2011 | - | $64.07M(-5.3%) | $245.65M(+3.2%) |
| Dec 2010 | $237.31M(-13.8%) | $67.63M(+12.7%) | $238.02M(+2.8%) |
| Sep 2010 | - | $60.02M(+11.3%) | $231.53M(-4.8%) |
| Jun 2010 | - | $53.94M(-4.4%) | $243.25M(-7.5%) |
| Mar 2010 | - | $56.44M(-7.7%) | $262.88M(-4.6%) |
| Dec 2009 | $275.33M(-19.4%) | $61.14M(-14.8%) | $275.44M(-3.8%) |
| Sep 2009 | - | $71.73M(-2.5%) | $286.39M(-1.4%) |
| Jun 2009 | - | $73.56M(+6.6%) | $290.48M(-6.1%) |
| Mar 2009 | - | $69.00M(-4.3%) | $309.26M(-5.2%) |
| Dec 2008 | $341.42M(+8.9%) | $72.10M(-4.9%) | $326.09M(-1.0%) |
| Sep 2008 | - | $75.82M(-17.9%) | $329.39M(+1.2%) |
| Jun 2008 | - | $92.34M(+7.6%) | $325.62M(+9.2%) |
| Mar 2008 | - | $85.83M(+13.9%) | $298.14M(+3.9%) |
| Dec 2007 | $313.57M(+13.2%) | $75.39M(+4.6%) | $286.93M(+7.7%) |
| Sep 2007 | - | $72.05M(+11.1%) | $266.45M(-0.1%) |
| Jun 2007 | - | $64.86M(-13.1%) | $266.60M(-0.2%) |
| Mar 2007 | - | $74.63M(+35.9%) | $267.00M(+3.0%) |
| Dec 2006 | $276.96M(+1.6%) | $54.91M(-23.9%) | $259.22M(-4.1%) |
| Sep 2006 | - | $72.19M(+10.6%) | $270.25M(+1.4%) |
| Jun 2006 | - | $65.27M(-2.4%) | $266.47M(+1.8%) |
| Mar 2006 | - | $66.84M(+1.4%) | $261.74M(-1.5%) |
| Dec 2005 | $272.63M(+31.9%) | $65.95M(-3.6%) | $265.71M(+3.9%) |
| Sep 2005 | - | $68.41M(+13.0%) | $255.69M(+7.6%) |
| Jun 2005 | - | $60.53M(-14.5%) | $237.53M(+3.8%) |
| Mar 2005 | - | $70.82M(+26.6%) | $228.90M(+11.4%) |
| Dec 2004 | $206.63M(+21.7%) | $55.93M(+11.3%) | $205.43M(+6.3%) |
| Sep 2004 | - | $50.25M(-3.2%) | $193.23M(+4.8%) |
| Jun 2004 | - | $51.90M(+9.6%) | $184.46M(+5.1%) |
| Mar 2004 | - | $47.35M(+8.3%) | $175.57M(+3.4%) |
| Dec 2003 | $169.82M(+16.1%) | $43.73M(+5.4%) | $169.74M(+3.8%) |
| Sep 2003 | - | $41.48M(-3.5%) | $163.57M(+1.6%) |
| Jun 2003 | - | $43.01M(+3.6%) | $160.94M(+4.6%) |
| Mar 2003 | - | $41.52M(+10.5%) | $153.93M(+5.2%) |
| Dec 2002 | $146.25M(+20.8%) | $37.56M(-3.3%) | $146.25M(+2.5%) |
| Sep 2002 | - | $38.85M(+7.9%) | $142.66M(+5.7%) |
| Jun 2002 | - | $36.00M(+6.4%) | $134.98M(+3.8%) |
| Mar 2002 | - | $33.84M(-0.4%) | $130.06M(+7.5%) |
| Dec 2001 | $121.03M(+47.9%) | $33.97M(+9.0%) | $121.03M(+14.9%) |
| Sep 2001 | - | $31.17M(+0.3%) | $105.33M(+9.4%) |
| Jun 2001 | - | $31.08M(+25.3%) | $96.27M(+9.8%) |
| Mar 2001 | - | $24.81M(+35.9%) | $87.64M(+4.6%) |
| Dec 2000 | $81.83M(+53.3%) | $18.26M(-17.4%) | $83.82M(+27.9%) |
| Sep 2000 | - | $22.11M(-1.6%) | $65.56M(+50.9%) |
| Jun 2000 | - | $22.46M(+7.0%) | $43.45M(+107.0%) |
| Mar 2000 | - | $20.99M | $20.99M |
| Dec 1999 | $53.36M(+15.5%) | - | - |
| Dec 1998 | $46.22M(+22.7%) | - | - |
| Dec 1997 | $37.67M(-1.9%) | - | - |
| Dec 1996 | $38.42M | - | - |
FAQ
- What is Charles River Laboratories International, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual EBITDA year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly EBITDA year-on-year change?
- What is Charles River Laboratories International, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. TTM EBITDA year-on-year change?
What is Charles River Laboratories International, Inc. annual EBITDA?
The current annual EBITDA of CRL is $928.62M
What is the all-time high annual EBITDA for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual EBITDA is $975.26M
What is Charles River Laboratories International, Inc. annual EBITDA year-on-year change?
Over the past year, CRL annual EBITDA has changed by -$46.64M (-4.78%)
What is Charles River Laboratories International, Inc. quarterly EBITDA?
The current quarterly EBITDA of CRL is $236.25M
What is the all-time high quarterly EBITDA for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly EBITDA is $265.20M
What is Charles River Laboratories International, Inc. quarterly EBITDA year-on-year change?
Over the past year, CRL quarterly EBITDA has changed by -$303.00K (-0.13%)
What is Charles River Laboratories International, Inc. TTM EBITDA?
The current TTM EBITDA of CRL is $907.49M
What is the all-time high TTM EBITDA for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high TTM EBITDA is $983.08M
What is Charles River Laboratories International, Inc. TTM EBITDA year-on-year change?
Over the past year, CRL TTM EBITDA has changed by -$43.91M (-4.62%)